MYCN and neuroblastoma: MTHFD1 was highly expressed in MYCN-amplified NB, and a high expression of MTHFD1 was associated with a poor prognosis of NB patients, suggesting that MTHFD1 may be associated with the malignant progression of MYCN-amplified NB.